Overview
Parasitic chorioretinitis involves inflammation of the choroid and retina caused by parasitic infections, often leading to significant visual impairment if untreated. These infections typically arise from complex life cycles involving vectors and intermediate hosts, posing diagnostic and therapeutic challenges 2.Diagnosis
Clinical Presentation: Retinal lesions, floaters, decreased visual acuity 2.
Ophthalmologic Examination: Fluorescein angiography, fundus photography to visualize lesions 2.
Laboratory Tests: Serological tests for specific antibodies, PCR for parasite DNA 2.
Grading: Severity often assessed based on lesion size, location, and visual field impact 2.Management
First-Line Treatment: Antiparasitic drugs such as Albendazole or Mebendazole (dose varies by parasite type) 2.
Adjunctive Therapy: Corticosteroids to reduce inflammation (consider in severe cases) 2.
Monitoring: Regular follow-up ophthalmologic exams to assess treatment efficacy and prevent complications 2.Special Populations
Pregnancy: Limited evidence; treatment should be individualized, prioritizing safety of mother and fetus 2.
Pediatrics: Early diagnosis and treatment crucial; dosing adjusted for age and weight 2.
Elderly: Increased vigilance for complications; consider comorbidities when selecting treatment 2.
Comorbidities: Management may need adjustment based on concurrent health conditions, requiring multidisciplinary care 2.Key Recommendations
Utilize serological tests and molecular diagnostics for accurate diagnosis of parasitic chorioretinitis (Evidence: Moderate 2).
Initiate treatment with antiparasitic agents tailored to the specific parasite identified, considering potential drug interactions in comorbid patients (Evidence: Moderate 2).
Regular ophthalmologic monitoring is essential for all patients to evaluate treatment response and prevent long-term visual impairment (Evidence: Expert opinion 2).References
1 Hotez PJ. A Journey in Science: Molecular vaccines for global child health in troubled times of anti-science. Molecular medicine (Cambridge, Mass.) 2024. link
2 Colley DG. Parasitic diseases: opportunities and challenges in the 21st century. Memorias do Instituto Oswaldo Cruz 2000. link